4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-18-057056
Executive VP, Drug Development sold 494 shares at $30.62 ($15,125)
- Executive VP, Drug Development acquired 494 shares (other)
From the SEC's structured data for this filing
Trades in this filing
MANHARD KIMBERLY · Executive VP, Drug Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-10-31 | Other acquisition : show line 1 in the form | +494 | $23.60 | $11,656 | 494 | D |
| 2018-11-02 | Sale : show line 2 in the form | −494 | $30.62 | $15,125 | 0 | D |
| Open-market sales · 494 sh · avg $30.62 · $15,125 | ||||||
Loading xslF345X03/doc4.xml…